Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

BACKGROUND: Intravesical chemotherapy and bacillus Calmette-Guérin (BCG) reduce the recurrence rate in patients with stage Ta T1 urothelial bladder cancer; however, the benefit of BCG relative to chemotherapy for long-term end points is controversial, especially in intermediate-risk patients. OBJECT...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Sylvester, Richard J., Brausi, Maurizio A., Kirkels, Wim J., Hoeltl, Wolfgang, Da Silva, Fernando Calais, Powell, Philip H., Prescott, Stephen, Kirkali, Ziya, van de Beek, Cees, Gorlia, Thierry, de Reijke, Theo M.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2009
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2889174/
https://ncbi.nlm.nih.gov/pubmed/20034729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2009.12.024
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items